65,437 trials
Domestic Violence
Primary: Intimate Partner Aggression as Measured by the Conflict Tactics Scale — 2.82; 2.51; 0.71; 1.69 Mean CTS Score
Type 2 Diabetes Mellitus
Primary: Change in Glycosylated Hemoglobin (HbA1c) Levels — -1.47; -2.00 percent of glycosylated Hb
Parkinson's Disease
Primary: Change From Baseline Moderate-Vigorous Physical Activity Using Actigraph at 4 Months — 2.27; 3.16; 76.96; 75.74 percentage of time
Primary Brain Tumors · Metastatic Malignant Neoplasm to Brain
Primary: Tumor Diameter — 2.7; 4.4 cm
Octreotide · Sputum
Primary: Bronchial Secretion Volume Over Preceding 24 Hour Period — 220; 310; 200; 70 mL/24 hr
Prostate Cancer
Primary: Tumor Growth Rate — 0.031; 0.030 unitless — p=0.74
Type 1 Diabetes · Type 2 Diabetes
Primary: Accuracy of Sensor Glucose Before and After Acetaminophen Administration — 9.46; 12.02; 16.98 Percent
Atypical Hemolytic Uremic Syndrome (aHUS)
Primary: Percentage Of Complement Inhibitor Treatment-naïve Participants With Complete Thrombotic Microangiopathy (TMA) Response at Week 26 — 77.8; 94.4; 88.9; 83.3 percentage of…
Blepharoptosis
Primary: Mean Change From Baseline in Intraocular Pressure (IOP) at Day 84 — -0.6; -0.2; -0.6; -0.2 mmHg
Cardiovascular Abnormalities
Primary: Change in Plasma Total Homocysteine Concentration (tHcy) — 1.9; 2.7; 0.5 mcmol/L — p=<0.05
Bacterial Vaginosis
Primary: Safety of LACTIN-V in Healthy Pre-menopausal Women. — 0; 0; 0; 0 participants
Acute Pain
Primary: Time Weighted Average (TWA) Change From Baseline in Pain Score Over 48 Hours Between TRV130 and Placebo — -3.1; -3.1; -2.6; -3.3 score on a scale
Educational Techniques
Primary: Changes in Medical Students' Patient-centredness as Assessed by the PPOS-D12 Questionnaire — 0.23; 0.32 units on a scale
Schizophrenia
Primary: Change From Baseline in the 16-Item Negative Symptom Assessment (NSA-16) Total Score at Week 6 and Week 12 — 61.0; 60.4; -5.0; -3.4 score on a scale — p=0.073
Advanced Cancers
Primary: Dyspnea Numeric Rating Scale — -2.4; -1.1 score on a scale